PCSK9: From discovery to therapeutic applications
Author:
Publisher
Elsevier BV
Subject
Cardiology and Cardiovascular Medicine,General Medicine
Reference49 articles.
1. Molecular spectrum of autosomal dominant hypercholesterolemia in France;Marduel;Hum Mutat,2010
2. The role of proprotein convertase subtilisin/kexin type 9 in hyperlipidemia: focus on therapeutic implications;Farnier;Am J Cardiovasc Drugs,2011
3. PCSK9 inhibition and LDL cholesterol lowering: the biology of an attractive therapeutic target and critical review of the latest clinical trials;Rhainds;Clin Lipid,2012
4. PCSK9 as a therapeutic target of dyslipidemia;Seidah;Expert Opin Ther Targets,2009
5. The biology and therapeutic targeting of the proprotein convertases;Seidah;Nat Rev Drug Discov,2012
Cited by 82 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Current and emerging monoclonal antibodies for treating familial hypercholesterolemia in children;Expert Opinion on Biological Therapy;2024-03-21
2. Role of proprotein convertase subtilisin/kexin type 9 (PCSK9) in diabetic complications;Canadian Journal of Physiology and Pharmacology;2024-01-01
3. Atherosclerosis, Diabetes Mellitus, and Cancer: Common Epidemiology, Shared Mechanisms, and Future Management;International Journal of Molecular Sciences;2023-07-22
4. Identification of Potent Small-Molecule PCSK9 Inhibitors Based on Quantitative Structure-Activity Relationship, Pharmacophore Modeling, and Molecular Docking Procedure;Current Problems in Cardiology;2023-06
5. Lipophagy: A Potential Therapeutic Target for Diabetic Nephropathy;Current Medicinal Chemistry;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3